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Purpose: The purpose of this study was to identify differences in signal transduction gene expression 
between normal and diabetic keratocytes stimulated with interleukin-1α (IL-1α) and tumor necrosis factor-α 
(TNF-α).
Methods:  Normal and diabetic keratocytes were primarily cultured and treated with 20 ng/ml IL-1α and 
TNF-α for 6 h. cDNA was hybridized to an oligonucleotide microarray. Genes identified by the microarray 
were further evaluated by real-time PCR. 
Results: Diabetic keratocytes over-expressed components of the MAPK and Notch pathways, and 
under-expressed components of the insulin, calcium, and TGF-β  pathways. Cytokine treated diabetic 
keratocytes differentially expressed components of the TGF-β and MAPK pathways. After IL-1α and TNF-α 
treatment, nine genes were under-expressed, falling in the insulin, TGF-β, and Toll-like receptor pathways. 
Real-time PCR showed a significant decrease in the IL-6 and TGF-β2 genes and a significant increase in 
the Ppm1a gene.
Conclusions: There were some differences in gene expression between normal and diabetic keratocytes 
related to signal transduction pathways, such as the insulin, MAPK, calcium, and TGF-β  pathways. In 
addition, IL-1α and TNF-α stimulating the insulin, TGF-β, and Toll-like receptor signaling pathways may have 
different effects in diabetic keratocytes.
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In diabetics, abnormalities are seen in the retina, lens, lid, 
iris, ciliary body, and nerves.
1,2 Diabetic corneal complications, 
such as abnormalities in the basement membrane of the 
corneal epithelium, barrier function impairment in the corneal 
epithelium, decreased corneal perception, abnormal collagen 
depositions in Descemet's membrane, morphological changes 
in corneal endothelial cells, and pump function deterioration 
are also common.
3-6 Hemidesmosomes and anchoring fibrils 
passing through the stroma in the adhesion complex are 
reduced, resulting in weakened hemidesmosome adhesion. As 
a result, preservation of the corneal epithelial layer (corneal 
epithelialization) is impaired. Furthermore, abnormalities in 
the corneal epithelial basement membrane may impair normal 
barrier function or induce edema in the corneal stromal area. 
Thus, depending on the healing of wound and inflammation 
there may be substantial impediments to tissues recovery.
3,4 
In addition, as the corneal endothelial cell pump function is 
damaged by diabetes, water is transported to the 
anterior corneal stromal tissues; therefore, particular 
cautions are required to reduce corneal complications 
such as keratitis.
5,6  
Cells respond to external stimulation by transducing 
extracellular signals from cell membrane receptors to 
cytoplasmic micromolecules. All biological activities of cells 
(apoptosis, proliferation, migration, polarity, and so on) are 
determined by various signal transduction pathways. 
Therefore, studies pertinent to signal control are very 
important.
7-10 In diabetes, morphological studies and reports 
on corneal cells are readily available; however, genetic and 
molecular studies on corneal stromal cells are relatively rare.
Furthermore, tissues react differently to cytokines in 
normal individuals, versus those with chronic diseases, such 
as diabetes, hypertension, or tumor lesions. These differences 
arise through differences in signal transduction pathway 
activation. We used microarrays and real-time polymerase 
chain reaction (real-time PCR) to measure the expression of 
genes or proteins involved in corneal stromal cell signal 
transduction. We compared normal cells in the spontaneously 
generated diabetes animal model (OLETF), with and without 
induction by pro-inflammatory cytokines.Kor J Ophthalmol Vol.21, No.2, 2007
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Materials and Methods
1. Cell culture. 
Fifty-week-old genetically-affected type 2 diabetic (OLETF, 
Otsuka Long-Evans Tokushima Fattay, Japan) and normal rat 
eyes were purchased from Otsuka pharmaceutical company 
(Japan). The corneal epithelium was removed, the corneal 
stroma isolated, and washed several times in saline containing 
antibiotics. The corneal endothelial layer was removed, and 
the corneal stromal tissue was cut into small pieces, and 
cultured serially in culture medium. The culture medium was 
Dulbeco's Modified Eagle medium (DMEM, Gibco BRL, 
NY, USA) containing 10 % fetal bovine serum (FBS, Gibco 
BRL. NY, USA), 100 units/ml penicillin (Gibco BRL, NY, 
USA), and 100 mg/ml streptomycin (Gibco BRL. NY, USA). 
The culture medium was changed at 2-3 day intervals. When 
the cells became confluent, the culture medium was removed, 
the cells were washed once with Dulbeco's Phosphate- 
Buffered Saline (D-PBS, Gibco BRL, NY, USA) and 
dissociated with 0.25 % trypsin-0.02 % EDTA. For 
microarray experiments, cells between the 3rd and 4th 
generation of serial culture were collected and stored at -70℃.
2. Cytokine treatment. 
The cytokines IL-1α (R&D Systems, MN, USA) and TNF( 
(R&D Systems, MN, USA) were used to treat the corneal 
stromal cells of diabetic and normal rats treated at a 
concentration of 20 ng/ml for 6 hours. 
3. RNA extraction. 
Total cellular RNAs were extracted from the corneal 
stromal cells of diabetic and normal rats in primary culture 
using the RNeasy mini kit (QIAGEN inc, 74104, USA) for 
gene microarrays. First, denaturing solution was added to cell 
pellets on ice for 5 min, then phenol and chloroform were 
added to the samples, they were centrifuged, and the 
supernatant containing RNA was transferred to a new tube. 
The process was repeated, and subsequently, -20℃ 
isopropanol was added to precipitate the RNA, centrifuged, 
and the supernatant discarded. The pellet was washed with 
-20℃ 80 % ethanol and air-dried. The RNA was quantitated 
and confirmed by electrophoresis.  
4. DNA gene microarrays. 
Sixty-mer oligonucleotides corresponding to each gene 
were synthesized, and subsequently placed on a slide using 
a robotic gene microarray. The robotic gene microarray 
places 0.25-1 nl DNA samples on a slide sample in spots 
averaging 100-150 nm. cDNA was synthesized from the 
isolated RNA samples using RT primers (Genisphere Inc, 
PA, USA) and SuperScript II reverse transcriptase 
(Invitrogen, NY, USA). The purified cDNA was hybridized 
to an Agilent Rat oligo 22K chip (Agilent tech, G4130A, 
USA). For hybridization, slides were placed in a dark 
hybridization chamber at 62℃  for 16 h. The slides were 
removed, washed 3 times, and dried using a centrifuge. A 
fluorescent dye was added to DNA capture reagents that bind 
RT primers, and a second hybridization was performed for 
4 h. The slides were removed, washed, and dried using a 
centrifuge. Afterward, the fluorescence level was measured 
using an Axon laser fluorescence scanner (Axon ins, CA, 
USA). The microarray analyzer used in our study has 105 
rows and 215 columns. A total of 22575 genes pertinent to 
the signal transduction were included. 
5. Analysis.
The hybridized slides were scanned by an Axon GenePix 
Laser Fluorescence Scanner and analyzed by GenePix Pro 5.1 
(Axon, CA, USA) and GeneSpring 7.0 (Silicongenetics, CA, 
USA). Genes showing more than a two-fold difference in 
expression level between normal and diabetic rats were 
classified as significant. Genes showing similar patterns were 
distinguished by a Pearson correlation. The images show a 
gene as red if it is up-regulated in the diabetic rat, and green 
if it is down-regulated.  
6. Real-time polymerase chain reaction. 
Real-time polymerase chain reaction (real time-PCR) was 
performed with SYBR Green I immunofluorescence dye and 
the HotStarTag DNA polymerase QuantiTect SYBR Green 
PCR Kit (QIAGEN GmbH, Germany). To quantitate the 
control group, a standard curve of genes to be tested and 
GAPDH was prepared. The reactions were carried out in an 
ABI PRISM 7900 Sequence Detection System version 1.6 
software (Perkin-Elmer Biosystems, Foster City, CA, USA). 
Relative quantitation measurements were performed applying 
the relative standard curve method according to the 
manufacturer's instructions. 
Results
The rats used in our experiments were 50-week-old Otsuka 
Long-Evans Tokushima Fatty (OLETF) diabetic rats. The 
blood glucose was an average of 115.0±10.8 mg/dL in the 
control group and 193.8±18.9 mg/dL in the OLETF group, 
with a significant difference. The body weights were 518.0±
13.3 g in the control group, and 628.5±63.2 g in OLETF 
rats. Thus, classic diabetes was observed. 
1. Comparison of expression in normal and diabetic 
corneal stromal cells 
A total of 33 genes showed different expression in diabetic 
corneal stromal cells compared to normal cells. These genes JE Lee, et al. SIGNAL TRANSDUCTION GENE IN DIABETIC RAT CORNEA
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signaling pathway Gene Symbol Accession No. Fold Change 
Insulin protein kinase cAMP-dependent regulatory type 1 alpha  Prkar1a CF110967 3.42
Fatty acid synthase Fasn NM017332 2.23
Acetyl-Coenzyme A carboxylase beta Acacb NM053922 -2.04
3-phosphoinositide dependent protein kinase-1 Pdpk1 NM031081 -2.04
Protein kinase C Pkcl AW918587 -2.17
Protein phosphatase 1 catalytic subunit beta isoform Ppp1cb NM013065 -2.22
Flotillin 1 Flot1 NM022701 -2.44
SHC transforming protein 1 Shc1 NM053517 -3.57
Growth factor receptor bound protein 2 Grb2 BC091144 -3.63
MAPK protein phosphatase 1A magnesium-dependent Ppm1a NM017038 12.77
Platelet derived growth factor alpha Pdgfa NM012801 5.26
V-jun sarcoma virus 17 oncogene homolog Jun NM021835 2.78
phospholipase A2 group IIA Pla2g2a NM031598 2.22
Dual specificity phosphatase 6 Dusp6 NM053883 2.17
Stathmin 1 Stmn1 NM017166 2.10
Activating transcription factor 4 Atf4 NM024403 2.00
Calcium Guanine nucleotide binding protein alpha 15 Gna15 NM053542 2.15
Ryanodine receptor 1 Ryr1 XM341818 -2.04
Cholecystokinin A receptor Cckar NM012688 -2.70
calcium channel voltage-dependent L type Cacna1d NM017298 -2.79
ATPase Ca++ transporting plasma membrane 1 Atp2b1 NM053311 -3.13
Adenosine A2B receptor Adora2b NM017161 -3.16
TGF-β CREB binding protein Crebbp NM133381 -2.00
Thrombospondin 2 TSP-2 NM013062 -2.38
inhibin beta B Inhbb XM344130 -6.73
decorin Dcn NM024129 -50.0
bone morphogenetic protein 4 Bmp4 NM012827 -100.0
Notch 1nicastrin Ncstn BC074006 2.22
Hairy and enhancer of split  Hes1 D13417 2.20
Phosphadyl-inositol inositol(myo)-1(or 4)-monophosphatase 1 Impa1 NM032057 -2.94
LIM domain kinase 2 Limk2 NM024135 -50.0
Wnt  seven in absentia 1A Siah1a NM080905 4.73
Jak-STAT Prolactin Prl NM012629 -2.13
Table 1. Up- and down-regulated genes in cultured diabetic rat keratocytes compared with normal rat keratocytes
are involved in the MAPK, calcium, TGF-β, Notch, 
phosphatidylinositol, Wnt, and Jak-STAT signal transduction 
pathways. In the insulin pathway, the cAMP-dependent 
regulatory type 1 αprotein kinase and fatty acid synthase 2 
were up-regulated, and 7 genes including the growth factor 
receptor bound protein 2, SHC transforming protein 1, and 
flotillin 1 were down-regulated. In the MAPK pathway, 7 
genes including magnesium-dependent protein phosphatase 
1A, platelet derived growth factor α, and V-jun (sarcoma 
virus 17 oncogene homolog) showed a difference in 
expression, all of which were up-regulated. In the calcium 
pathway, guanine nucleotide binding protein α15 was 
up-regulated, while the adenosine A2B receptor, ATPase 
Ca
++ transporting plasma membrane 1, and calcium channel 
voltage dependent L type genes were down-regulated. In the 
TGF-β  pathway, BMP 4, decorin, inhibin βB, CREB 
binding protein, and thrombospondin 2 genes were 
down-regulated. In the Notch pathway, the hairy, enhancer of 
split 1, and Inicastrin genes were up-regulated. The genes 
involved in the Wnt signaling pathway were up-regulated. 
The inositol (myo)-1(or 4)-monophosphatase 1 and LIM 
domain kinase 2 genes in the phosphatidylinositol signal 
pathway and the prolactin gene in the Jak-STAT pathway 
were down-regulated (Table 1).
2. Comparison of expression following cytokine treatment
2.1. Comparison of gene expression in normal and diabetic 
corneal stromal cells after  cytokine treatment.
After cytokine treatment, there were differences between 
normal and diabetic cells in genes related to the TGF-β, 
MAPK, insulin, Phosphatidylinositol, Wnt, calcium, and Kor J Ophthalmol Vol.21, No.2, 2007
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Signaling pathway Gene Symbol Accession No.
Fold Change
I
* II
† III
‡
TGF-β CREB binding protein Crebbp NM133381 -2.00 -4.56 -2.90
inhibin beta B Inhbb XM344130 -6.73 -7.51 -4.01
decorin Dcn NM024129 -50.0 -5.26 -8.33
bone morphogenetic protein 4 Bmp4 NM012827 -100.0 -100.0 -100.0
Sp1 transcription factor Sp1 NM012655 -3.23 -2.63 -
Thrombospondin 4 Thbs4 X89963 -2.00 - -3.13
MAPK  protein phosphatase 1A magnesium-dependent Ppm1a NM017038 12.77 6.67 7.47
Platelet derived growth factor alpha Pdgfa NM012801 5.26 6.67 9.09
phospholipase A2 group IIA Pla2g2a NM031598 2.22 3.03 2.56
FBJ murine osteosarcoma viral oncogene homolog c-fos NM022197 5.00 - 2.63
Jun D proto-oncogene Jund NM138875 2.22 - 2.63
Calcium calcium channel voltage-dependent L type Cacna1d NM017298 -2.79 -3.25 -3.60
Peptidylprolyl isomerase D Ppid NM1004279 -3.76 -4.94 -
Cell division cycle 2 homolog A Cdc2a NM019296 -3.42 - -2.11
Angiotensin II type-1 receptor Agtr1 NM031009 -6.08 - -37.44
Insulin  protein kinase cAMP-dependent regulatory type 1 alpha  Prkar1a CF110967 3.42 6.65 3.87
Protein kinase C Pkcl AW918587 -2.17 -2.94 -2.94
SHC transforming protein 1 Shc1 NM053517 -3.57 -2.44 -4.00
Phosphadyl-inosito
l 
inositol(myo)-1(or 4)-monophosphatase 1 Impa1 NM032057 -2.94 -3.70 -3.85
LIM domain kinase 2 Limk2 NM024135 -50.0 -25.00 -16.67
CDP-diacylglycerol synthase 1 cds1 NM031242 -2.63 - -2.86
Wnt  seven in absentia 1A Siah1a NM080905 4.73 5.13 3.06
Secreted frizzled-related protein 1 Sfrp1 XM227314 5.26 6.67 -
Notch nicastrin Ncstn BC074006 2.22 2.04 2.33
* The ratio of gene expression in diabetic rat stromal keratocytes compared with normal rat stromal keratocytes.
†The ratio of gene expression following Interleukin-1α (IL-1α) treatment.
‡The ratio of gene expession following Tumor necrosis factor-α (TNF-α) treatment.
Table 2. Up- and down-regulated genes involved in corneal keratocyte signal transduction expressed in diabetic rat following cytokine 
treatment 
Notch signal pathways. None of the Jak-STAT pathway 
genes, including prolactin, were different. Three genes were 
unresponsive to TNF–α and responded to IL-1α; The Sp1 
transcription factor (TGF-β  pathway) and Peptidylprolyl 
isomerase D (calcium pathway) were down-regulated, and the 
Secreted frizzled related synthase 1 gene (Wnt pathway) was 
up-regulated. Several genes were unresponsive to IL-1α and 
responded to TNF–α; Thrombospondin 4 (TGF-β), cell 
division cycle 2 homolog A and Angiotensin II type-I 
receptor gene (calcium), CDP diacylglycerol synthase 1 gene 
(phosphatidylinositol) were expressed at lower than normal 
levels, and the FBJ murine osteosarcoma viral oncogene 
homolog and Jun D proto-oncogene gene (MAPK) were 
up-regulated (Table 2). 
2.2. Genes newly expressed after IL-1α treatment.
IL-1α treatment induced expression of 14 genes belonging 
to the Jak-STAT, Toll-like receptor, calcium, MAPK, Wnt, 
and insulin pathways. Six genes were up-regulated, including 
Sphingosine kinase 1 (calcium), CD38 antigen gene, 
Neutrophic tyrosine kinase II (MAPK), Nuclear receptor 
subfamily 4 group A member 1 gene and Axin 2 (Wnt), and 
the Wnt inhibitory factor 1 gene. Eight genes were 
down-regulated, primarily in the Toll-like receptor, insulin, 
and Jak-STAT pathways (Table 3).
2.3. Genes newly expressed after TNF-α treatment.
TNF–α  treatment induced expression of genes in the 
calcium, MAPK, insulin, Toll-like receptor, Wnt, and Notch 
signal pathways. The MAPK, Wnt, and Notch pathways were 
up-regulated, while the calcium, insulin, and Toll-like 
receptor pathways were down-regulated. All genes were 
down-regulated (Table 4).
2.4. New gene expression common to both IL-1α and TNF
–α treatment.
IL-1α and TNF-α stimulation both induced expression of 
nine genes in the insulin, TGF-β, Toll-like receptor, and 
adipocytokine pathways. In the insulin signal pathway, V-srk 
sarcoma virus CT 10 oncogene, suppressor of cytokine 
signaling 2, and liver glycogen phophorylase gene were 
expressed and down-regulated compared to control. JE Lee, et al. SIGNAL TRANSDUCTION GENE IN DIABETIC RAT CORNEA
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Signaling pathway Gene Symbol Acession No. Fold Change 
Toll-like receptor Phosphatidylinositol 3-kinase regulatory subunit polypeptide 1 Pik3r1 NM013005 -2.00
Interleukin 1 beta Il1b NM031512 -2.22
G4 protein Tnf XM579722 -2.26
Toll-like receptor 2 Tlr2 NM198769 -4.55
Mitogen-activated protein kinase kinase 6 Map2k6 NM053703 -4.71
Calcium Sphingosine kinase 1 Sphk1 NM133386 2.04
CD38 antigen Cd38 NM013127 2.03
Adenylate cyclase 5 Adcy5 AW144517 -2.33
MAPK Neurotrophic tyrosine kinase, receptor type 2 Ntrk2 CB544493 3.41
Nuclear receptor subfamily 4 group A member 1 Nr4a1 NM024388 3.12
Wnt Axin2 Axin2 NM024355 2.47
Wnt inhibitory factor 1 Wif1 NM053738 2.04
Insulin Inositol polyphosphate-5-phosphatase D Inpp5d NM019311 -2.14
Jak-STAT Ciliary neurotrophic factor Cntf NM013166 -2.06
Table 3. Gene up- and down-regulated for newly expressed genes following interleukin-1α treatment in cultured
diabetic rat keratocytes compared with normal rat keratocytes 
Signaling pathway Gene Symbol Acession No. Changes (X) 
Calcium Hypothetical gene Pdgfrb NM031525 -2.08
Arginine vasopressin receptor 1A Avpr1a NM053019 -2.08
Coagulation factor II receptor F2r NM012950 -2.08
Purinergic receptor P2X ligand-gated ion channel 4 P2rx4 NM031594 -2.22
Phospholamban Pln NM022707 -3.03
MAPK Heat shock 27kD protein 2 Hspb2 NM130431 2.5
V-raf murine sarcoma viral oncogene homolog B1 Braf XM231692 2.22
RAS guanyl releasing protein 4 Rasgrp4 NM130824 2.08
TAO kinase 2 Tao2 NM022702 2.04
Notch Jagged 1 Jag1 NM019147 2.50
Notch gene homolog 2 Notch2 NM024358 2.07
Toll-like receptor Interferon, beta 1 Ifnb1 NM019127 -3.70
Insulin Fructose-1,6-bisphosphatase 2 Fbp2 NM053716 -2.17
Wnt Protein phosphatase 2 regulatory subunit A alpha isoform Ppp2r1a BG667851 2.38
Table 4. Gene up- and down-regulated for newly expressed genes following tumor necrosis factor-α treatment in
cultured diabetic rat keratocytes compared with normal rat keratocytes 
Signaling pathway Gene Symbol Acession No.
Changes(X) 
I
* II
†
Insulin V-crk sarcoma virus CT10 oncogene  Crk NM019302 -2.04 -2.70
suppressor of cytokine signaling 2 Socs2 NM058208 -2.09 -2.11
Liver glycogen phosphorylase Pygl NM022268 -2.5 -3.57
TGF-β   follistatin Fst NM012561 -2.33 -2.56
transforming growth factor beta 2 Tgfb2 NM031131 -2.38 -3.57
bone morphogenetic protein 2 Bmp2 BF559333 -2.00 -5.00
Toll-like Receptor interleukin 6 Il6 NM012589 -2.02 -3.23
chemokine ligand 5 Ccl5 NM031116 -3.03 -3.03
Adipocytokine neuropeptide Y Npy NM012614 -33.33 -12.5
* The ratio gene expression following Interleukin-1α (IL-1α) treatment.
†The ratio gene expression following tumor necrosis factor-α (TNF-α) treatment.
Table 5. Gene up- and down-regulated for newly expressed genes following treatment with both interleukin-1α and tumor necrosis 
factor-α in cultured diabetic rat keratocytes compared with normal rat keratocytes Kor J Ophthalmol Vol.21, No.2, 2007
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Fig. 1. Quantitative real-time PCR of three genes using GAPDH as an endogenous control. "*" indicates a significant difference 
between normal and diabetic rats stimulated with or without IL-1α or TNF-α. IL-6 and TGF-β 2 showed no significant difference 
between untreated normal and diabetic rat, but the diabetic rat showed a significant down-regulation when cytokine treated. Ppm1a 
showed a significant  up-regulation in all diabetic cases.
The follistatin (TGF-β), TGF-β 2, BMP 2, IL-6, and 
chemokine ligand 5 genes (Toll-like receptor), and 
Neuropeptide Y (adipocytokine) were down-regulated (Table 5).  
3. Real-time PCR
Real-time PCR was performed on three genes that differed 
significantly between normal and diabetic rats, or were 
induced by cytokine treatment. The genes selected were IL-6, 
Ppm 1A, and TGF-β2. The primer sets and annealing 
temperatures are shown in Table 6. These genes showed up- 
or down-regulation identical to the gene microarray results. 
For IL-6 and TGF-β2, no significant difference between 
diabetic and normal cells was seen. After cytokine treatment, 
they showed significant down-regulation. The Ppm 1A gene 
showed a significant up-regulation in diabetes, as compared 
to the control and was up-regulated by cytokine treatment 
(Fig. 1).
Discussion 
In multicellular organisms, biological activities are 
controlled by cellular signals. Diverse signal transduction 
pathways regulate apoptosis, proliferation, migration, polarity, 
and other processes.
10 In corneal tissues, the interaction 
between the stromal and epithelial layers plays an important 
role in proliferation, migration, differentiation, morphogenesis, 
and other functions. Furthermore, it has been shown to 
contribute to homeostasis in the ocular surface and wound 
healing.
11,12
Abnormal signal transduction between the stroma and 
epithelial layers may result in impaired corneal tissue 
development or delayed wound healing. In diabetics, reduced 
corneal perception, an abnormal corneal epithelial basement 
complex, and impaired corneal epithelium barrier function 
develop. Furthermore, spot-like corneal epithelial defects, 
delayed corneal epithelium regeneration after trauma, and 
neurotrophic keratitis are common as well.
3-6 Therefore, 
studies on genes pertinent to corneal signal transduction 
pathways are important for understanding the mechanism of 
corneal diseases induced by diabetes.
In our study, the expression of genes associated with signal 
transduction in normal corneal stroma cells was compared to 
expression in diabetic corneal stromal cells. The purpose of 
this study is to provide a basis of gene therapy by identifying 
gene alterations induced by diabetes. In addition, we 
compared genes related to signal transduction following 
cytokine stimulation. Responses to inflammatory reactions 
were examined using IL-1α and TNF-α. 
Generally, when the corneal epithelial layer is damaged, 
the tissue secretes cytokines. While corneal stromal cells 
undergo apoptosis, the cytokines induce chemotaxis, 
proliferation of activated stromal cells, and excessive 
secretion of extracellular matrix substances such as collagen, JE Lee, et al. SIGNAL TRANSDUCTION GENE IN DIABETIC RAT CORNEA
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Gene Primer sequence (5'-3') Annealing temperature (℃) PCR product size (bp)
IL6 F: CCTGGAGTTTGTGAAGAACAACT
R: GGAAGTTGGGGTAGGAAGGA 60 142
Ppm1a F: TGGGTGAGGGACTACAGCTT
R: GAAATCACGCTTACATAAGTCTCAAA 60 94
Tgfb2 F: GTGTTTTCATCATGCTGGCT
R: CGTGAAGTGGCTGTTGATCT 60 115
F: Forward; R: Reverse.
Table 6. Real-time PCR primers
eventually resulting in corneal wound recovery. IL-1α and 
TNF-α are representative of the cytokines involved in this 
process.
9,13,14 Because the cytokines are primarily secreted 
from damaged corneal epithelial cells,
14 corneal stromal cells 
were exposed to IL-1α and TNF–α for approximately 6 
hours. This time is sufficient to mimic the effect of cytokines 
released in response to corneal epithelial layer damage. Genes 
expressed at that time were classified as normal or diabetic 
and compared with each other.
The insulin, MAPK, calcium, and TGF-β  pathways 
showed a large difference in expression between normal and 
diabetic corneal stromal cells. It has been shown that the 
insulin pathway improved the migration capacity of cells and 
thus accelerated wound healing instead of suppressing cell 
proliferation, following epithelial defect in corneal epithelial 
cells.
15 In other words, the delayed wound healing that has 
been detected frequently in diabetes could be explained by 
abnormal insulin signaling. In our study, 5 of 6 insulin signal 
transduction genes were down-regulated.
The MAPK signal pathway has 3 subtypes, the c-jun 
N-terminal kinase (JNK) pathway, the extracellular 
signal-regulated kinase (ERK) pathway, and the p38 MAPK 
pathway. Upon activating the MAPK pathway, the tight 
junction in corneal epithelial cells is destroyed. Thus the 
pathway plays an important role in morphological control and 
corneal epithelial cell barrier function.
16,17 All 7 genes 
involved in the MAPK signal pathway were up-regulated in 
diabetic corneal stromal cells.
Changes, such as cell migration and proliferation, are 
required for wound healing upon corneal epithelium damage 
requiring signal transduction among cells. Calcium-dependent 
signal transduction is required to convert extracellular 
stimulation to intercellular signal transduction. Calcium levels 
are increased in corneal epithelial cells in response to 
mechanical damage, transducing the signal to adjacent cells, 
thus facilitating wound healing.
18,19 Therefore, our study 
suggests, that wound healing is delayed when corneal tissues 
are damaged in diabetics, because calcium signal transduction 
genes are down-regulated. It is thought that a deficiency of 
calcium-dependent signal transduction between adjacent cells 
may delay wound healing.
The TGF-β receptor is up-regulated after corneal wound, 
suggesting that the TGF-β signal pathway may play a role 
in repairing corneal epithelial cells.
20 In addition, TGF-β 
controls corneal stromal cell and myofibroblast differentiation. 
Thus it has a role in scar formation in the wound healing 
process.
21 Because the expression of pertinent TGF-β genes 
was decreased markedly, delayed wound healing in diabetes 
may be associated with the abnormal TGF-β signaling.
In the drosophila eye, Notch induced cell proliferation, but 
blocked cell differentiation in the primordial. The expression 
of Notch-related genes was up-regulated in diabetes.
22 
Although the cell proliferation occurs to heal corneal tissue 
wounds, the cell differentiation is not overly active, as to 
impair the normal eye surface.
The Jak-STAT pathway mediates the action of growth 
factors such as epidermal growth factor. Prolactin, a 
Jak-STAT gene, expression was decreased.
23,24 This may 
explain why cell proliferation at the corneal surface layer is 
not active in diabetes.
Genes associated with the TGF-β, MAPK, insulin, 
phosphatidylinositol, Wnt, calcium, and Notch signal 
pathways reacted to IL-1α and TNF-α treatment. Among 
genes reactive to IL-1α, Sp1 transcription factor (TGF-β) and 
peptidylprolyl isomerase D (calcium) were down-regulated, 
and secreted frizzled related protein 1 (Wnt) was 
up-regulated. All were unresponsive to TNF–α. Secreted 
frizzled related protein 1 had a distinct expression level. It 
has been shown to play a role in controlling axonal growth 
in retinal ganglion cells and impeding the wound healing 
process. Thus it is thought to be associated with delayed 
wound healing in diabetes.
25,26 Thrombospondin 4 (TGF-β), 
cell division cycle 2 homolog A and angiotensin II type-I 
receptor (calcium), and CDP diacylglycerol synthase 1 
(phosphatidylinositol) were down-regulated, and FBJ murine 
osteosarcoma viral oncogene homolog and Jun D 
proto-oncogene gene (MAPK) were up-regulated in response 
to TNF–α and unresponsive to IL-1α. The angiotensin II 
type-I receptor gene showed a marked reduction that is 
primarily associated with delayed wound healing after 
conjunctival injury. It has been reported that the expression 
is decreased in diabetes, thus delaying wound repair.
27,28
Genes newly expressed after IL-1α  treatment were 
associated with the Toll-like receptor, calcium, MAPK, Wnt, 
insulin, and the Jak-STAT signal pathways. Sphingosine 
kinase 1, and CD38 antigen (calcium), Neutrophic tyrosine Kor J Ophthalmol Vol.21, No.2, 2007
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kinase II, and Nuclear receptor subfamily 4 group A member 
1 (MAPK), and axin 2, and Wnt inhibitory factor 1 (Wnt) 
were up-regulated. Reduced expression was associated with 
the Toll-like receptor, insulin, Jak-STAT pathways. Toll-like 
receptor 2 and mitogen activated protein kinase 6 were 
down-regulated. 
The Toll-like receptor signal pathway was especially 
involved following cytokine treatment. This pathway has 
been shown to be involved in the host defense mechanism. 
In other words, it is involved in both innate and acquired 
immune responses.
29 According to our results, the expression 
of all genes associated with the Toll-like receptor was 
reduced in diabetes following inflammatory reaction. In 
diabetics the in vivo immune system reaction to cytokines is 
decreased; thus, in diabetes, the inflammatory response is 
weak. The host innate immune response is involved in 
infectious keratosis, and thus decreased noticeably in 
response to cytokines.
30
In diabetes, genes associated with the calcium, MAPK, 
Notch, Toll-like receptor, insulin, and Wnt signal pathway 
were newly expressed after TNF–α treatment. The MAPK, 
Notch, and Wnt pathways were up-regulated, and the 
calcium, insulin, and Toll-like receptor pathways were 
down-regulated. Gene expression was decreased in all cases. 
Interferon  β1 and phospholamban showed marked 
down-regulation. Interferon β1 has been reported to elevate 
anti-viral effects in the cornea. In diabetes with a concomitant 
inflammatory reaction, a reduced anti-viral effect can be 
detected due to immune system damage.
31
Genes associated with the insulin, TGF-β, Toll-like 
receptor, and adipocytokine pathways were newly expressed 
in response to both IL-1α and TNF-α. The V-crk sarcoma 
virus CT 10 oncogene, suppressor of cytokine signaling 2, 
and liver glycogen phosphorylase (insulin), follistatin, TGF-β 
2, and BMP 2 (TGF-β), IL-6 and chemokine ligand 5 
(Toll-like receptor), and Neuropeptide Y (adipocytokine) 
were down-regulated. Reduced Neuropeptide Y expression 
may delay angiogenesis and thus prolong wound healing.
32 
We further characterized several genes by real-time PCR, 
including Ppm 1A, which showed significant up-regulation 
after cytokine treatment. We also characterized TGF-β 2 and 
IL-6, which were down-regulated by cytokine treatment. The 
expression pattern was identical to the microarray analysis 
results.
By applying a microarray, we were able to observe 
differentially expressed genes pertinent to signal transduction 
pathways between normal and diabetic corneal stromal cells. 
By examining up- or down-regulated genes in diabetes, the 
signal transduction pathways involved in delayed wound 
healing and inflammatory response could be assessed. By 
looking at gene expression in response to interleukin or tumor 
necrosis factor, it is anticipated that genetic treatments for 
diabetic keratopathy and to prevent delayed corneal wound 
healing may be possible in the future.
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